BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 24, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
July 26, 2004
View Archived Issues
Phase I studies evaluate the effects of SPD-754 on the metabolism of other anti-HIV drugs
Read More
Novel class of HIV-1 entry inhibitors targets gp120-binding domain of CD4
Read More
A recombinant vaccine shows promise in the prevention of SARS
Read More
Signet outlines plans for efforts in sepsis and acute renal failure
Read More
Celera Genomics and Seattle Genetics to develop antibody therapies for cancer
Read More
Several drugs show efficacy in the treatment of HIV-associated lipodystrophy
Read More
Hypocholesterolemic compound reduces Abeta levels in vivo
Read More
PBI-1393 activates CTLs and induces IL-2 and IFN-gamma synthesis
Read More
Flurbiprofen analogues reduce beta-amyloid release without affecting COX-1 activity
Read More
FDA to grant additional six months pediatric exclusivity to clofarabine
Read More
AzaSite enters two phase III studies for acute bacterial conjunctivitis
Read More
ViroPharma to advance maribavir into phase II
Read More
Atrix licenses BEMA technology to Arius
Read More
Pfizer to discontinue development of sumanirole
Read More
Access updates progress of AP-5346
Read More
DMAG enters phase I
Read More
Evotec to support Morphochem's development of Oxaquin
Read More
NEC discovers new peptide-vaccine candidates for hepatitis C
Read More
LY-450139 reported to reduce the levels of amyloid beta in plasma and CSF
Read More
Farnesoid X receptor agonists
Read More
New JNK3 inhibitors with potential utility in cerebral ischemia
Read More
Selective 5-HT6 antagonists claimed by Roche
Read More
Prodrugs of MPV-2426 described by Orion
Read More
Boehringer Ingelheim discloses anti-HIV agents
Read More
Glucokinase activators described by Novartis
Read More